Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/669757


South Africa In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012


Description: South Africa In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the South Africa In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in South Africa

Scope

- The report provides in vitro diagnostics information broken down into detailed categories and segments in South Africa.
- Total revenues, end users
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in South Africa.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of Markets Covered in the Report 13
3.1 In Vitro Diagnostics Devices 13
3.2 Clinical Chemistry Test Reagents 13
3.2.1 Laboratory Reagents 13
3.2.2 Clinical Chemistry Calibrators and Controls 13
3.2.3 Clinical Chemistry Rapid Tests 13
3.3 Immunochemistry Test Reagents 13
3.3.1 Disease Specific Markers 13
3.3.2 Disease Specific Test Reagents 14
3.3.3 Drug Related Testing Reagents 14
3.3.4 Hormone Related Testing Reagents 15
3.3.5 Immunochemistry Calibrators and Controls 15
3.3.6 Immunochemistry Rapid Tests 15
3.4 Blood Test Reagents 16
3.4.1 Hematology Test Reagents 16
3.4.2 Hemostasis Test Reagents 16
3.4.3 Tissue Typing Reagents 17
3.4.4 Monoclonal Antibodies 17
3.4.5 Cytokines and Immunomodulators 17
3.4.6 Histology and Cytology Reagents 17
3.5 Microbiology Test Reagents 17
3.5.1 Bacteriology Test Reagents 17
3.5.2 Microbiology Calibrators and Controls 18
3.5.3 Microbiology Rapid Tests 18
3.6 Infectious Immunology Test Reagents 18
3.6.1 Bacteriology 18
3.6.2 Virology 18
3.6.3 Parasitology 18
3.6.4 Infectious Immunology Calibrators and Controls 18
3.6.5 Infectious Immunology Rapid Tests 19
3.7 Genetic Test Reagents 19
3.8 Self Testing 19
3.9 Instruments 19
4 Healthcare Sector Review 20
5 Regulation System 21
5.1 Medical Equipment Regulation System 21
5.2 Regulation of Electromagnetic Medical Devices 21
5.3 Future Outlook 24
6 Pricing and Reimbursement 25
6.1 Reimbursement 25
6.2 Pricing 25
7 Distribution Structure 26
8 In Vitro Diagnostics In South Africa 27
8.1 In Vitro Diagnostics Cross Country Comparison (2000-2012) 27
8.2 In Vitro Diagnostics, South Africa, Overall Revenues ($ mn), 2000-2012 28
8.3 In Vitro Diagnostics, South Africa Company share (2006-2007) 34
9 Blood Test Reagents In South Africa 35
9.1 Blood Test Reagents Overall Revenue (2000-2012) 35
9.1.1 Haematology Test Reagents Overall Revenues (2000-2012) 39
9.1.2 Hemostasis Test Reagents Overall Revenues (2000-2012) 41
9.2 Blood Test Reagents Distribution Share (2006-2007) 43
9.3 Blood Test Reagents, South Africa, Company Share (2006-2007) 44
10 Clinical Chemistry Test Reagents In South Africa 45
10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2012) 45
10.2 Clinical Chemistry Test Reagents Distribution Share (2006-2007) 47
10.3 Clinical Chemistry Test Reagents, South Africa, Company Share (2006-2007) 48
11 Genetic Test Reagents In South Africa 49
11.1 Genetic Test Reagents Overall Revenue (2000-2012) 49
11.2 Genetic Test Reagents Distribution Share (2006-2007) 51
11.3 Genetic Test Reagents, South Africa, Company Share (2006-2007) 52
12 Immunochemistry Test Reagents In South Africa 53
12.1 Immunochemistry Test Reagents Overall Revenue (2000-2012) 53
12.1.1 Disease Specific Markers Overall Revenues (2000-2012) 57
12.1.2 Disease Specific Test Reagents Overall Revenues (2000-2012) 59
12.1.3 Drug Related Testing Reagents Overall Revenues (2000-2012) 61
12.1.4 Hormone Related Testing Reagents Overall Revenues (2000-2012) 63
12.2 Immunochemistry Test Reagents Distribution Share (2006-2007) 65
12.3 Immunochemistry Test Reagents, South Africa, Company Share (2006-2007) 66
13 Infectious Immunology Test Reagents In South Africa 67
13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2012) 67
13.1.1 Virology Overall Revenues (2000-2012) 70
13.2 Infectious Immunology Test Reagents Distribution Share (2006-2007) 72
13.3 Infectious Immunology Test Reagents, South Africa, Company Share (2006-2007) 73
14 Instruments In South Africa 74
14.1 Instruments Overall Revenue (2000-2012) 74
14.2 Instruments Distribution Share (2006-2007) 76
14.3 Instruments, South Africa, Company Share (2006-2007) 77
15 Microbiology Test Reagents In South Africa 78
15.1 Microbiology Test Reagents Overall Revenue (2000-2012) 78
15.1.1 Bacteriology Test Reagents Overall revenues (2000-2012) 79
15.2 Microbiology Test Reagents Distribution Share (2006-2007) 81
15.3 Microbiology Test Reagents, South Africa, Company Share (2006-2007) 82
16 Self Testing In South Africa 83
16.1 Self Testing Overall Revenue (2000-2012) 83
16.2 Self Testing Distribution Share (2006-2007) 85
16.3 Self Testing, South Africa, Company Share (2006-2007) 86
17 F. Hoffmann-La Roche Ltd. Company Profile 87
17.1 Company Overview 87
17.2 Value Chain Analysis 87
17.2.1 Manufacturing 88
17.2.2 Product Development 88
17.2.3 Sales and Marketing 89
18 Abbott Laboratories Company Profile 91
18.1 Company Overview 91
18.2 Value Chain Analysis 91
18.2.1 Manufacturing 92
18.2.2 Product Development 92
18.2.3 Sales and Marketing 93
18.2.4 Abbott Laboratories Pipeline Products by Equipment Type 93
18.2.5 Abbott Laboratories Pipeline Products by Development Stage 94
18.2.6 Abbott Laboratories Pipeline Products by Therapy Area 94
18.2.7 Abbott Laboratories Pipeline Products by Clinical Trials 94
18.2.8 Abbott Laboratories Pipeline Products by News Summary 94
19 Siemens Medical Solutions Company Profile 95
19.1 Company Overview 95
19.2 Value Chain Analysis 95
19.2.1 Manufacturing 96
19.2.2 Product Development 96
19.2.3 Sales and Marketing 96
19.3 Siemens Medical Solutions Pipeline Products 97
19.3.1 Siemens Medical Solutions Pipeline Products by Equipment Type 97
19.3.2 Siemens Medical Solutions Pipeline Products by Development Stage 97
19.3.3 Siemens Medical Solutions Pipeline Products By Therapy Area 98
19.3.4 Siemens Medical Solutions Pipeline Products By News Summary 98
20 Dade Behring Holdings, Inc. Company Profile 99
20.1 Company Overview 99
20.1.1 Dade Behring Holdings, Inc. Pipeline Products by Equipment Type 100
20.1.2 Dade Behring Holdings, Inc. Pipeline Products by Development Stage 100
20.1.3 Dade Behring Holdings, Inc. Pipeline Products by Therapy Area 100
20.1.4 Dade Behring Holdings, Inc. Pipeline Products by News Summary 100
21 Beckman Coulter, Inc. Company Profile 101
21.1 Company Overview 101
21.2 Value Chain Analysis 101
21.2.1 Manufacturing 102
21.2.2 Product Development 102
21.2.3 Sales and Marketing 102
21.3 Beckman Coulter, Inc. Pipeline Products 103
21.3.1 Beckman Coulter, Inc. Pipeline Products by Equipment Type 103
21.3.2 Beckman Coulter, Inc. Pipeline Products by Development Stage 104
21.3.3 Beckman Coulter, Inc. Pipeline Products by Therapy Area 105
21.3.4 Beckman Coulter, Inc. Pipeline Products by News Summary 105
22 Ortho-Clinical Diagnostics Inc. Company Profile 106
22.1 Company Overview 106
23 Makromed Manufacturing (Pty) Ltd Company Profile 107
23.1 Company Overview 107
24 Appendix 108
24.1 Global Markets Direct Research Methodology 108
24.2 Coverage 109
24.3 Secondary Research 109
24.4 Primary Research 110
24.5 Models 110
24.6 Forecasts 111
24.7 Expert Panels 111
24.8 Currency Conversion 112
24.9 Contact Us 113
24.10 Disclaimer 113

Executive Summary

1.2 List of Figures
Figure 1: In Vitro Diagnostics Cross Country Comparison (2000-2012) 27
Figure 2: In Vitro Diagnostics, South Africa, Overall Revenues ($ mn), 2000-2012 28
Figure 3: In Vitro Diagnostics, South Africa, Portfolio Analysis, 2000-2012 29
Figure 4: In Vitro Diagnostics, South Africa, Overall Revenues ($ mn), Historic, 2000-2007 30
Figure 5: In Vitro Diagnostics, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012 32
Figure 6: In Vitro Diagnostics, South Africa Company share (%), 2007 34
Figure 7: Blood Test Reagents, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 35
Figure 8: Blood Test Reagents, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 37
Figure 9: Haematology Test Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 39
Figure 10: Haematology Test Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 40
Figure 11: Hemostasis Test Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 41
Figure 12: Hemostasis Test Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 42
Figure 13: Blood Test Reagents, South Africa, Company Share (%), 2007 44
Figure 14: Clinical Chemistry Test Reagents, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 45
Figure 15: Clinical Chemistry Test Reagents, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Figure 16: Clinical Chemistry Test Reagents, South Africa, Company Share (%), 2007 48
Figure 17: Genetic Test Reagents, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 49
Figure 18: Genetic Test Reagents, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 50
Figure 19: Genetic Test Reagents, South Africa, Company Share (%), 2007 52
Figure 20: Immunochemistry Test Reagents, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 53
Figure 21: Immunochemistry Test Reagents, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 55
Figure 22: Disease Specific Markers, South Africa, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 57
Figure 23: Disease Specific Markers, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 58
Figure 24: Disease Specific Test Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 59
Figure 25: Disease Specific Test Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 60
Figure 26: Drug Related Testing Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 61
Figure 27: Drug Related Testing Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 62
Figure 28: Hormone Related Testing Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 64
Figure 29: Immunochemistry Test Reagents, South Africa, Company Share (%), 2007 66
Figure 30: Infectious Immunology Test Reagents, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 67
Figure 31: Infectious Immunology Test Reagents, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 69
Figure 32: Virology, South Africa, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 70
Figure 33: Virology, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 71
Figure 34: Infectious Immunology Test Reagents, South Africa, Company Share (%), 2007 73
Figure 35: Instruments, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 74
Figure 36: Instruments, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 75
Figure 37: Bacteriology Test Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 79
Figure 38: Bacteriology Test Reagents, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 80
Figure 39: : Microbiology Test Reagents, South Africa, Company Share (%), 2007 82
Figure 40: Self Testing, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 83
Figure 41: Self Testing, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 84
Figure 42: Self Testing, South Africa, Company Share (%), 2007 86
Figure 43: F. Hoffmann-La Roche Ltd Value Chain Analysis 87
Figure 44: Abbott Laboratories Value Chain Analysis 91
Figure 45: Siemens Medical Solutions Value Chain Analysis 95
Figure 46: Beckman Coulter, Inc. Value Chain Analysis 101
Figure 47: Global Markets Direct Methodology 108


Companies Mentioned F. Hoffmann-La Roche Ltd. Abbott Laboratories Siemens Medical Solutions Dade Behring Holdings, Inc. Beckman Coulter, Inc. Ortho-Clinical Diagnostics Inc. Makromed Manufacturing (Pty) Ltd


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/669757

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 17/02/2012 02:11:27
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
South Africa In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012
Web Address:
http://www.researchandmarkets.com/reports/669757
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,263.00
Electronic (PDF) - Site License €4,527.00
Electronic (PDF) - Enterprisewide €6,790.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 17/02/2012 02:11:27

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)